Skip to content

GYN Specialists

Akila N. Viswanathan, MD, MPH

Associate Professor, Harvard Medical School
Radiation Oncologist, Brigham and Women’s Hospital

Dr. Viswanathan is a board certified radiation oncologists and Associate Professor at Harvard Medical School. Dr. Viswanathan specializes in gynecologic malignancies and image-guided brachytherapy. At the Dana-Farber/Brigham and Women’s, she led the development and growth of the gynecology practice and designed clinical trials of real-time MRI-based image-guided brachytherapy and CT-based imaging for gynecologic cancer patients. She implemented the first use of IMRT techniques at the Dana-Farber/Brigham and Women’s for selected gynecologic cancer patients. In addition to clinical outcomes, Dr. Viswanathan’s research focuses on risk factors and prevention of endometrial cancer.  She is actively involved in protocol development, serving as principal investigator for an accruing trial, and works with the Radiation Therapy Oncology Group Gynecology Steering Committee to study novel therapeutics in gynecologic cancers.

Christine Fisher, MD, MPH

Assistant Professor of Radiation Oncology
University of Colorado School of Medicine

Dr. Fisher is a board certified Assistant Professor in the Department of Radiation Oncology at University of Colorado. Dr. Fisher is an active member of the University of Colorado’s Breast Center and Multidisciplinary Breast Cancer Clinic, as well as in many professional organizations including the American Society for Radiation Oncology (ASTRO), American Brachytherapy Society (ABS), American Society for Clinical Oncology (ASCO), and Alpha Omega Alpha Medical Honor Society (AOA). She has published numerous scientific articles and regularly presents her research at national and international scientific meetings. She currently serves as Medical Student Program Director and Associate Residency Program Director for the Department of Radiation Oncology.

David Gaffney, MD, PhD

Vice Chair and Professor of Radiation Oncology at the University of Utah
Senior Director for Clinical Research at the Huntsman Cancer Institute

David Gaffney’s main research interests are in clinical trial development, prognostic markers, radiation sensitizers, and secondary cancers. He is an active clinician and specializes in the radiotherapeutic management of gynecological cancers, breast cancers, and lymphoma. Dr. Gaffney is interested in clinical trials that improve survival and quality of life for cancer patients. He serves as a co-Chair for the National Cancer Institute Gynecologic Cancer Steering Committee and previously was chair of the Gynecologic Working Group for the Radiation Therapy Oncology Group (RTOG). He is a past chair of the American Brachytherapy Society and the Cervix Cancer Research Network. He is active in the Gynecologic Cancer Intergroup, a worldwide organization of clinical trial groups. He also chairs the Clinical Research Executive Committee at the Huntsman Cancer Institute and serves as a Senior Editor for the International Journal of Gynecologic Cancer, Gynecologic Oncology, and the American Journal of Clinical Oncology, and Brachytherapy.

Beth Erickson, MD, FACR, FASTRO, FABS

Professor, Department of Radiation Oncology
J. Frank and Vera B. Wilson Professorship in Radiation Oncology
Medical College of Wisconsin, Milwaukee, WI

Dr. Beth Erickson is tenured professor and fulltime faculty at the Medical College of Wisconsin and the J. Frank and Vera B. Wilson Professorship in Radiation Oncology. She has written and spoken nationally and internationally on the treatment of Gynecologic and Gastrointestinal malignancies, with a special interest in image-based treatment planning. She has served as a liaison to GEC ESTRO and on the ICRU 89 committee She has been continually active in the American Brachytherapy Society, serving as a member of the board and past president, as well as the ABS GYN Brachytherapy School since its 1995 inception. She was honored with the Henschke Award( 2014) and the Dr. Thom Shanahan Distinguished Brachytherapy Educator Award (2018). She served as section head editor for Gyn for the Journal of Brachytherapy International. Dr. Erickson served as Vice-Chair of the Cervix Committee for the Patterns of Care and QRRO Studies and has served as Chair of the ACR Practice Guidelines for the performance of high dose rate and low dose rate brachytherapy. She has also been active in the Radiological Society of North America, Co-Chairing the Oncologic Imaging and Therapies Task Force and delivering the 2020 Annual Oration in Radiation Oncology. She has been active in ASTRO with teaching activities as well as numerous committees including the MOC/CME, Education, Nominating, and Fellowship as well as serving as Gyn Track Chair and as a member of the Cervical Guideline Task Force. She was Chair of the ASTRO Endometrial Cancer Guideline Task Force and the Annual Refresher Course. She also served as chair of the Education Council for the ASTRO Board of Directors. She was named Medical College of Wisconsin Alumnus of the Year in 2019.

Professor, Department of Radiation Oncology
Division of Radiation Oncology
The University of Texas MD Anderson Cancer Center, Houston, TX

Dr. Anuja Jhingran earned her M.D. at Texas Tech University in 1988, followed by residency training at Baylor College of Medicine in Internal Medicine and Radiation Oncology. She began her career as an Assistant Professor at The University of Texas MD Anderson Cancer Center in 1996 and has grown and advanced to Professor of Radiation Oncology in the Section of Gynecology. She is a physician specializing in the treatment of gynecologic cancers. Clinically, she is interested in the management of advanced ovarian, cervical, and endometrial cancers and the use of advanced radiation techniques to minimize toxicity. In addition, Dr. Jhingran is heavily involved with the Radiation Therapy Oncology Group (RTOG) and Gynecologic Oncology Group (GOG), in the development of patient care studies to treat gynecologic cancers and has been the national Principal Investigator of several studies, including a phase III study in cervical cancer. Dr. Jhingran is also an active member of the Gynecologic Cancer InterGroup. Dr. Jhingran travels extensively internationally for cancer education. She is passionate about women’s health issues and especially as it relates to developing country’s efforts to establish improved healthcare for the general populace, not just the financially able.

Back To Top